[Pharmacological study of (naphtyloxy-1)4-hydroxy-3 butyramidoxime chlorhydrate or LL 1530. Anti-arrhythmic action].
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D000440:Butanols / Q000494:pharmacology; D006224:Cricetinae; D004285:Dogs; D006329:Heart Conduction System / Q000187:drug effects; D009281:Naphthalenes / Q000494:pharmacology; D010091:Oximes / Q000494:pharmacology*; D011802:Quinidine / Q000494:pharmacology; D051381:Rats
D000889:Anti-Arrhythmia Agents; D000440:Butanols; D009281:Naphthalenes; D010091:Oximes; D011802:Quinidine; C006154:nadoxolol
Etude pharmacologique du chlorhydrate de (naphtyloxy-1)-4-hydroxy-3 butyramidoxime, ou LL 1530. Activité anti-arythmisante